Merit Medical Systems (MMSI) Net Equity Issued and Repurchased (2010 - 2026)

Merit Medical Systems (MMSI) has 17 years of Net Equity Issued and Repurchased data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 78.9% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (down 61.5% YoY), and the FY2025 full-year result was $28.2 million, down 31.03% from the prior year.
• Net Equity Issued and Repurchased slipped to $2.8 million in Q1 2026, from $6.0 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $25.5 million in Q4 2024 to a low of $1.6 million in Q2 2022.
• A 5-year average of $6.3 million and a median of $4.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased surged 515.85% in 2024 and sank 78.9% in 2026, its largest moves.
• Tracing MMSI's Net Equity Issued and Repurchased over 5 years: stood at $13.3 million in 2022, then sank by 68.97% to $4.1 million in 2023, then surged by 515.85% to $25.5 million in 2024, then tumbled by 76.32% to $6.0 million in 2025, then sank by 54.01% to $2.8 million in 2026.
• Business Quant data shows MMSI's Net Equity Issued and Repurchased at $2.8 million in Q1 2026, $6.0 million in Q4 2025, and $2.2 million in Q3 2025.